SAFETYLIT WEEKLY UPDATE

We compile citations and summaries of about 400 new articles every week.
RSS Feed

HELP: Tutorials | FAQ
CONTACT US: Contact info

Search Results

Journal Article

Citation

Mukherjee S, Sen S, Ghosal M, Tripathi S. Int. J. Basic Clin. Pharmacol. 2014; 3(4): 738.

Copyright

(Copyright © 2014, Medip Academy)

DOI

10.5455/2319-2003.ijbcp20140821

PMID

unavailable

Abstract

This report describes a patient suffering from somatoform disorder that developed suicidal ideation specifically due to the treatment with sertraline. After 6-7 months on the regimen, she presented slight suicidal ideations. However, with gradual progress of time and continuation of the therapy, the ideation became intense. She complained of intense restlessness and anxiety. She presented with fresh cuts and bruises on her left arm and neck. On reporting the problem, the drug was withdrawn. Patient experienced gradual improvement in her state. The case report underlines the importance of onset of suicide risk in panic disorders due to specific antidepressants, selective serotonin reuptake inhibitors (SSRIs). The exact neurobiological basis of depression though being uncertain, the role of serotonin has been mostly implicated. Hypothetically, biological alterations in the serotonergic system might have contributed to the suicidal ideation/attempt in the presence of an SSRI. The present case attempts to highlight an incidence of development of suicidal ideation in a patient who is on chronic SSRI therapy. Key words: Selective serotonin reuptake inhibitors, Sertraline, Suicidal ideation


Language: en

NEW SEARCH


All SafetyLit records are available for automatic download to Zotero & Mendeley
Print